Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…
- The Company is developing an enhanced immunosuppressive regimen in consultation with a panel of multi-disciplinary clinical experts and engaging…
LOS ANGELES--(BUSINESS WIRE)--This summer, PlayLA Youth & Adaptive Youth Sports Program, the City of Los Angeles Department of Recreation and…